docetaxel,enzalutamide
astellas,pfizer
['enzalu', 'cspc', 'enzalutamide', 'cspc ']
results from lci s investigator-initiated enzada trial: androgen deprivation therapy with doc &amp; enzalutamide (enz) improve the 52-week psa cr rate for newly diagnosed mcspc patients findings align with recent studies, supporting future use of combination therapies #asco23 
Levine Cancer Institute is home to top providers, cutting-edge treatments and groundbreaking clinical trials. Our expert care helps patients heal – and thrive.